BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Convertible Redeemable Preferred Stock And Stockholders' Equity - Summary our stock warrants measured at fair value (Details)

Convertible Redeemable Preferred Stock And Stockholders' Equity - Summary our stock warrants measured at fair value (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Temporary Equity And Stockholders Equity [Line Items]
Beginning Balance, December 31, 2023	$ 1,363
Fair Value Adjustment	(514)	$ (78)
Ending Balance, June 30, 2024	2,616
Fair value recurring \| Level 3
Temporary Equity And Stockholders Equity [Line Items]
Beginning Balance, December 31, 2023	1,363
Additions	3,851
Exercises	(2,055)
Fair Value Adjustment	(543)
Ending Balance, June 30, 2024	2,616
Series H Warrants [Member] \| Fair value recurring \| Level 3
Temporary Equity And Stockholders Equity [Line Items]
Beginning Balance, December 31, 2023	620
Fair Value Adjustment	56
Ending Balance, June 30, 2024	676
Series J Warrants [Member] \| Fair value recurring \| Level 3
Temporary Equity And Stockholders Equity [Line Items]
Beginning Balance, December 31, 2023	743
Exercises	(95)
Fair Value Adjustment	(16)
Ending Balance, June 30, 2024	632
Class A Common Warrants [Member] \| Fair value recurring \| Level 3
Temporary Equity And Stockholders Equity [Line Items]
Additions	2,280
Exercises	(1,960)
Fair Value Adjustment	(106)
Ending Balance, June 30, 2024	214
Class B Common Warrants [Member] \| Fair value recurring \| Level 3
Temporary Equity And Stockholders Equity [Line Items]
Additions	1,379
Fair Value Adjustment	(419)
Ending Balance, June 30, 2024	960
Investor Warrants \| Fair value recurring \| Level 3
Temporary Equity And Stockholders Equity [Line Items]
Additions	192
Fair Value Adjustment	(58)
Ending Balance, June 30, 2024	$ 134